In a letter published in Gut, Norwegian researchers comment on two recent studies linking the use of acid-reducing proton pump inhibitors, or PPIs, to gastric cancer. Hong Kong researchers published findings in early November that long-term PPIs use, even after Helicobacter pylori eradication therapy, is still associated with an increased risk of gastric cancer. At the same time a Swedish study reported incidence of gastric cancer to be linked to long-term PPI use. In their letter titled, “Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man,” Professor Helge Lyder Waldum, Department of Clinical ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.